Synonyms: compound 1 [PMID: 22582973] | MDG-548 | MDG548
Compound class:
Synthetic organic
Comment: MDG 548 is a peroxisome proliferator-activated receptor γ (PPARγ) agonist that was identified by virtual screening, and validated by in vitro assays [3].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Lecca D, Janda E, Mulas G, Diana A, Martino C, Angius F, Spolitu S, Casu MA, Simbula G, Boi L et al.. (2018)
Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models. Br J Pharmacol, 175 (16): 3298-3314. [PMID:29570770] |
2. Lecca D, Nevin DK, Mulas G, Casu MA, Diana A, Rossi D, Sacchetti G, Carta AR. (2015)
Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice. Neuroscience, 302: 23-35. [PMID:25907448] |
3. Nevin DK, Peters MB, Carta G, Fayne D, Lloyd DG. (2012)
Integrated virtual screening for the identification of novel and selective peroxisome proliferator-activated receptor (PPAR) scaffolds. J Med Chem, 55 (11): 4978-89. [PMID:22582973] |